Screener
Arbutus Biopharma Corporation ABUS Business Segments — Other segment expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept abus:OtherSegmentExpense.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed August 12, 2026.
- Filed
- Aug 12, 2026, 7:31 AM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q3 2026
- Accession
- 0001447028-26-000045
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other research and development expense | 2,389 | 2,142 | 5,092 | 7,031 |
| General and administrative expense | 3,867 | 3,328 | 9,756 | 9,160 |
| Restructuring expense | — | 165 | — | 12,538 |
| Other segment expense (1) | 234 | 267 | 471 | 590 |
| Add: | ||||
| Interest income | 842 | 1,042 | 1,657 | 2,239 |
| Segment net income (loss) | $(5,143) | $2,523 | $164,552 | $(22,003) |
| Adjustments and reconciling items | — | — | — | — |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Arbutus Biopharma Corporation's business segments — other segment expense?
- Arbutus Biopharma Corporation (ABUS) reported business segments — other segment expense of $234K in Q2 2026.
- How has Arbutus Biopharma Corporation's business segments — other segment expense changed year-over-year?
- Arbutus Biopharma Corporation's business segments — other segment expense decreased by 12.4% year-over-year, from $267K to $234K.
- What is the long-term trend for Arbutus Biopharma Corporation's business segments — other segment expense?
- Over 2 years (2023 to 2025), Arbutus Biopharma Corporation's business segments — other segment expense has grown at a 86.4% compound annual growth rate (CAGR), from $503K to -$1.75M.
- What does business segments — other segment expense mean?
- This category captures miscellaneous operational expenses within the segment that do not fall under specific R&D or administrative classifications. It is used to reconcile the segment's total operating costs.
Ask your AI about Arbutus Biopharma Corporation's business segments — other segment expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude